TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2015

Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial.

Sameer Bakhshi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.